Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A production A/B experiment on a real ride-hailing platform with statistically significant improvements in key metrics, but the work is a preprint, lacks peer review, reports only summary results without detailed effect sizes or confidence intervals, and is described as an engineering system deployment rather than a clinical or definitive health/safety study.
First-in-class preclinical work demonstrating a novel nanoparticle approach in animal xenograft models; lacks human efficacy data, controlled comparators, and peer-reviewed publication details required for clinical translation.